[{"Assets_0_Q3_USD":96467000.0,"CommonStockSharesOutstanding_0_Q3_shares":24051364.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-53488000.0,"NetIncomeLoss_1_Q3_USD":-17338000.0,"NetIncomeLoss_3_Q3_USD":-55124000.0,"StockholdersEquity_0_Q3_USD":64274000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":379000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":1138000.0,"Ticker":"SNDX","CIK":"1395937","name":"SYNDAX PHARMACEUTICALS INC","OfficialName":"Syndax Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"934158860.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20181105"}]